Amdocs Limited Stock Year To Date Return
AOS Stock | EUR 75.84 0.46 0.60% |
Fundamental analysis of Amdocs allows traders to better anticipate movements in Amdocs' stock price by examining its financial health and performance throughout various phases of its business cycle.
Amdocs |
Amdocs Limited Company Year To Date Return Analysis
Amdocs' Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
More About Year To Date Return | All Equity Analysis
YTD Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
Competition |
In accordance with the company's disclosures, Amdocs Limited has a Year To Date Return of 0.0%. This indicator is about the same for the Technology average (which is currently at 0.0) sector and about the same as Software - Infrastructure (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
Amdocs Fundamentals
Return On Equity | 0.15 | |||
Return On Asset | 0.0652 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.15 % | |||
Current Valuation | 10.29 B | |||
Shares Outstanding | 120.59 M | |||
Shares Owned By Insiders | 0.01 % | |||
Shares Owned By Institutions | 98.75 % | |||
Price To Earning | 22.06 X | |||
Price To Book | 2.98 X | |||
Price To Sales | 2.22 X | |||
Revenue | 4.58 B | |||
Gross Profit | 1.62 B | |||
EBITDA | 899.33 M | |||
Net Income | 549.5 M | |||
Cash And Equivalents | 449.7 M | |||
Cash Per Share | 3.28 X | |||
Total Debt | 645.12 M | |||
Debt To Equity | 3.30 % | |||
Current Ratio | 1.35 X | |||
Book Value Per Share | 29.42 X | |||
Cash Flow From Operations | 756.72 M | |||
Earnings Per Share | 4.18 X | |||
Price To Earnings To Growth | 1.14 X | |||
Target Price | 87.75 | |||
Number Of Employees | 31 K | |||
Beta | 0.66 | |||
Market Capitalization | 10.24 B | |||
Total Asset | 6.39 B | |||
Z Score | 9.0 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 1.35 % | |||
Net Asset | 6.39 B | |||
Last Dividend Paid | 1.58 |
About Amdocs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amdocs Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Amdocs Stock
Amdocs financial ratios help investors to determine whether Amdocs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amdocs with respect to the benefits of owning Amdocs security.